Xvivo Perfusion AB XVIPF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $33.53
- Day Range
- $32.20–32.20
- 52-Week Range
- $19.90–33.53
- Bid/Ask
- $32.47 / $32.87
- Market Cap
- $1.01 Bil
- Volume/Avg
- 100 / 244
Key Statistics
- Price/Earnings (Normalized)
- 94.43
- Price/Sales
- 16.79
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 130
- Website
- https://www.xvivoperfusion.com
Comparables
Valuation
|
Metric
|
XVIPF
|
MCAP
|
CALTX
|
|---|---|---|---|
Price/Earnings (Normalized) | 94.43 | 39.65 | — |
Price/Book Value | 5.64 | 6.11 | 16.09 |
Price/Sales | 16.79 | 3.95 | 4.46 |
Price/Cash Flow | 106.02 | 21.09 | — |
Price/Earnings
XVIPF
MCAP
CALTX
Financial Strength
|
Metric
|
XVIPF
|
MCAP
|
CALTX
|
|---|---|---|---|
Quick Ratio | 3.40 | 1.35 | 2.85 |
Current Ratio | 4.16 | 2.23 | 3.13 |
Interest Coverage | — | 14.80 | −5.64 |
Quick Ratio
XVIPF
MCAP
CALTX
Profitability
|
Metric
|
XVIPF
|
MCAP
|
CALTX
|
|---|---|---|---|
Return on Assets (Normalized) | 4.96% | 10.75% | −24.68% |
Return on Equity (Normalized) | 5.74% | 17.72% | −89.92% |
Return on Invested Capital (Normalized) | 4.82% | 13.91% | −31.14% |
Return on Assets
XVIPF
MCAP
CALTX
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Mzcdgjrfc | Xgmyvd | $185.5 Bil | |
SYK
| Stryker Corp | Vfrdzbzgm | Sjpw | $128.2 Bil | |
MDT
| Medtronic PLC | Snfrhzlb | Whyqr | $106.7 Bil | |
BSX
| Boston Scientific Corp | Dqswfsbh | Dpsmwb | $99.0 Bil | |
DXCM
| DexCom Inc | Djqwbjlrf | Skmp | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Qbgzqfwwh | Ddwypx | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Ywmfflgnk | Flyr | $24.9 Bil | |
ALGN
| Align Technology Inc | Vnrtszgb | Zwmvt | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Blfhcvcq | Rfynj | $18.9 Bil | |
PODD
| Insulet Corp | Hxyjyynp | Vxqvrv | $11.7 Bil |